5
R J Bio-Tech
536456 BSE
R J Bio-Tech
Fast Moving Consumer Goods BSE: 536456 Agricultural Food & other Products
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
1- Company has low interest coverage ratio.
Growth Rate
Net Income Growth
99% higher than
3Y
Quarterly Results
| Particulars | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5 | 7 | 2 | 15 | 11 | 6 | 4 | 0 | 0 | 0 | 7 | 0 | 2 |
| Expenses | 4 | 6 | 2 | 13 | 7 | 4 | 6 | 0 | 11 | 0 | 9 | 0 | 8 |
| Operating Profit | 1 | 2 | 0 | 2 | 4 | 2 | -3 | 0 | -11 | 0 | -1 | 0 | -6 |
| OPM % | 22% | 21% | -22% | 16% | 37% | 33% | -73% | — | -11922% | — | -20% | 100% | -374% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 0 | 2 | 0 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0 | 1 | -2 | 1 | 3 | 1 | -4 | 0 | -13 | 0 | -3 | 0 | -17 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — | 0% | — | 0% | — | 0% |
| Net Profit | 0 | 1 | -2 | 1 | 3 | 1 | -4 | 0 | -13 | 0 | -3 | 0 | -17 |
| EPS in Rs | 0.1 | 0.67 | -1.84 | 1.55 | 3.36 | 1.21 | -3.74 | 0 | -13.54 | 0 | -3.54 | 0 | -18.39 |
Profit & Loss
| Particulars | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.39 | 23.14 | 24.63 | 29.69 | 11.91 | 7.04 | 7.73 | 10.21 | 12.65 | 11.34 | 0 | 0 |
| Expenses | 14.38 | 17.18 | 18.86 | 23.53 | 23.07 | 14.93 | 15.11 | 13.7 | 25.27 | 10.02 | 0.79 | 0.01 |
| Operating Profit | 4.01 | 5.96 | 5.77 | 6.16 | -11.16 | -7.89 | -7.38 | -3.49 | -12.62 | 1.32 | -0.79 | -0.01 |
| OPM % | 21.81% | 25.76% | 23.43% | 20.75% | -93.7% | -112.07% | -95.47% | -34.18% | -99.76% | 11.64% | — | — |
| Other Income | 0 | 0 | 0 | 0 | 0.06 | -8.69 | 0.14 | 0.21 | -2.97 | 0.52 | 0.55 | 0 |
| Interest | 2.34 | 2.64 | 3.6 | 3.44 | 3.6 | 3.89 | 4.14 | 0.78 | 0 | 5.82 | 0 | 0 |
| Depreciation | 0.36 | 0.45 | 0.7 | 0.44 | 0.32 | 0.3 | 0.15 | 0.1 | 0.09 | 0.07 | 0.01 | 0.01 |
| PBT | 1.31 | 2.87 | 1.47 | 2.28 | -15.02 | -20.77 | -11.53 | -4.16 | -15.68 | -4.05 | -0.25 | -0.02 |
| Tax % | 0% | 0% | 0% | 0.44% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 1.3 | 2.87 | 1.46 | 2.27 | -15.02 | -20.77 | -11.53 | -4.16 | -15.68 | -4.05 | -0.25 | -0.01 |
| EPS in Rs | 1.87 | 3.03 | 1.54 | 2.4 | -15.86 | -21.94 | -12.18 | -4.39 | -16.56 | -4.28 | -0.26 | -0.01 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.97 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | — | — |
| Reserves | 7.51 | 12.88 | 14.23 | 16.5 | 1.49 | -19.28 | -30.81 | -34.97 | -50.65 | -59.81 | — | — |
| Borrowings | 19.8 | 24.77 | 26.81 | 24.86 | 29.63 | 37.25 | 41.5 | 42.1 | 40.54 | 51.14 | — | — |
| Other Liabilities | 6.28 | 10.9 | 10.36 | 9.06 | 6.94 | 7.64 | 7.62 | 8.82 | 6.5 | 1.11 | — | — |
| Total Liabilities | 40.56 | 58.02 | 60.87 | 59.89 | 47.53 | 35.08 | 27.78 | 25.42 | 5.86 | 1.91 | — | — |
| Fixed Assets | 2.91 | 2.99 | 2.41 | 2.12 | 1.95 | 1.84 | 1.75 | 1.72 | 1.75 | 1.53 | — | — |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Other Assets | 37.65 | 55.03 | 58.46 | 57.77 | 45.58 | 33.24 | 26.03 | 23.7 | 4.11 | 0.38 | — | — |
| Total Assets | 40.56 | 58.02 | 60.87 | 59.89 | 47.53 | 35.08 | 27.78 | 25.42 | 5.86 | 1.91 | — | — |
Cash Flow
| Particulars | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 3.88 | -5.12 | 2.47 | 5.79 | 0.07 | -2.69 | 0.84 | 0.71 | 1.96 | -4.72 | 0.7 | -0.8 |
| Investing | -2.37 | -2.18 | -1.66 | -1.35 | -0.84 | -0.82 | -0.77 | -0.67 | -0.37 | 0 | 0.09 | 0 |
| Financing | -2.67 | 7.63 | -0.95 | -4.84 | 0.82 | 3.45 | -0.03 | -0.06 | -1.54 | 4.68 | 0 | 0 |
| Net Cash Flow | -1.16 | 0.33 | -0.14 | -0.4 | 0.05 | -0.05 | 0.04 | -0.02 | 0.05 | -0.04 | 0.79 | -0.8 |
| Free Cash Flow | 3.66 | -5.53 | 2.35 | 5.76 | 0.09 | -2.77 | 0.78 | 0.64 | 1.85 | -4.72 | 0.79 | -0.8 |
| CFO/OP | 101 | -86 | 43 | 94 | -1 | 34 | -11 | -20 | -16 | -386 | -89 | 8,000 |
Ratios
| Particulars | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 172 | 179 | 238 | 294 | 582 | 863 | 473 | 263 | 23.95 | 9.01 | — | — |
| Inventory Days | 1,123 | 1,198 | 1,368 | 765 | 689 | 637 | 798 | 837 | 30.46 | 0 | — | — |
| Days Payable | 45.83 | 115 | 107 | 63.88 | 54.78 | 157 | 151 | 170 | 11.6 | — | — | — |
| Cash Conversion Cycle | 1,249 | 1,263 | 1,498 | 995 | 1,216 | 1,342 | 1,121 | 930 | 42.8 | 9.01 | — | — |
| Working Capital Days | 237 | 304 | 318 | 276 | 282 | -390 | -892 | -820 | -1,129 | -1,547 | — | — |
| ROCE % | 10.95% | 13.54% | 10.39% | 11.29% | -25.11% | -23.67% | -31.05% | -18.88% | -159.27% | 2400% | — | — |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view R J Bio-Tech insights
56 extracted metrics + investor summaries across FY12–FY24.
Documents
1
Announcement under Regulation 30 (LODR)-Newspaper Publication
19 Feb - Copies Newspaper Advertisement(s) of Notice regarding Special Window for Re-lodgement of Transfer Requests and Dematerialisation of Physical Shares. 19 Feb - Copies Newspaper Advertisement(s) of Notice regarding Special Window for Re-lodgement of Transfer Requests and Dematerialisation of Physical Shares.
3
Board Meeting Outcome for Unaudited Financial Results, Both On Standalone And Consolidated Basis, For Quarter And Nine Months Ended On 31St December, 2025.
13 Feb - Unaudited Q3/9M results approved; auditor adverse review cites Rs.2,86,050 lakh ICDs, going-concern uncertainty and large debt exposure. 13 Feb - Unaudited Q3/9M results approved; auditor adverse review cites Rs.2,86,050 lakh ICDs, going-concern uncertainty and large debt exposure.
4
Unaudited Financial Results For Quarter Ended 31.12.2025
13 Feb - Approved unaudited results for quarter/nine months ended Dec 31, 2025; auditors flagged going-concern, ICDs Rs.2,76,109 lakhs 13 Feb - Approved unaudited results for quarter/nine months ended Dec 31, 2025; auditors flagged going-concern, ICDs Rs.2,76,109 lakhs
5
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results, Both On Standalone And Consolidated Basis, For Quarter And Nine Months Ended On 31St December, 2025.
6 Feb - Board meeting on 13 Feb 2026 to approve Q3/9M unaudited results ended 31 Dec 2025; trading window remains closed. 6 Feb - Board meeting on 13 Feb 2026 to approve Q3/9M unaudited results ended 31 Dec 2025; trading window remains closed.
3
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP) 26 Oct 2024
Company Update
4
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP) 25 Oct 2024
Company Update
Frequently Asked Questions about R J Bio-Tech
What does R J Bio-Tech Ltd do?
Incorporated in 2005, R J Biotech Limited develops proprietary hybrids with nutritional and economical traits in Fiber crops, Cereal crops and Vegetable crops
Where is R J Bio-Tech Ltd (536456) listed?
R J Bio-Tech Ltd trades under code 536456 on the BSE.
Which sector does R J Bio-Tech Ltd belong to?
R J Bio-Tech Ltd is classified under the Fast Moving Consumer Goods sector, in the Agricultural Food & other Products industry.
Company Information
Incorporated in 2005, R J Biotech Limited develops proprietary hybrids with nutritional and economical traits in Fiber crops, Cereal crops and Vegetable crops
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/536456.md for R J Bio-Tech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.